These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 26094162

  • 1. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR.
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [Abstract] [Full Text] [Related]

  • 2. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM, VOICE Study Team.
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [Abstract] [Full Text] [Related]

  • 3. Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.
    Socías ME, Duff P, Shoveller J, Montaner JSG, Nguyen P, Ogilvie G, Shannon K.
    Sex Transm Infect; 2017 Jun; 93(4):284-289. PubMed ID: 27821613
    [Abstract] [Full Text] [Related]

  • 4. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.
    Lancet; 2019 Jul 27; 394(10195):303-313. PubMed ID: 31204114
    [Abstract] [Full Text] [Related]

  • 5. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
    Polis CB, Nakigozi GF, Nakawooya H, Mondo G, Makumbi F, Gray RH, Members of the Rakai Health Sciences Program Sayana Press study team.
    Contraception; 2014 May 27; 89(5):385-95. PubMed ID: 24332432
    [Abstract] [Full Text] [Related]

  • 6. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
    Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA, Hayes RJ, Heffron R, Kapiga S, Karim QA, Karpoff S, Kaul R, McClelland RS, McCormack S, McGrath N, Myer L, Rees H, van der Straten A, Watson-Jones D, van de Wijgert JH, Stalter R, Low N.
    PLoS Med; 2015 Jan 27; 12(1):e1001778. PubMed ID: 25612136
    [Abstract] [Full Text] [Related]

  • 7. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK.
    Contraception; 2012 Dec 27; 86(6):645-52. PubMed ID: 22541635
    [Abstract] [Full Text] [Related]

  • 8. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C, Baeten JM, Partners PrEP Study Team.
    AIDS; 2014 Nov 28; 28(18):2771-6. PubMed ID: 25493602
    [Abstract] [Full Text] [Related]

  • 9. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L, Denny L, Wright TC, Kuhn L.
    Int J Epidemiol; 2007 Feb 28; 36(1):166-74. PubMed ID: 17175547
    [Abstract] [Full Text] [Related]

  • 10. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
    Byrne EH, Anahtar MN, Cohen KE, Moodley A, Padavattan N, Ismail N, Bowman BA, Olson GS, Mabhula A, Leslie A, Ndung'u T, Walker BD, Ghebremichael MS, Dong KL, Kwon DS.
    Lancet Infect Dis; 2016 Apr 28; 16(4):441-8. PubMed ID: 26723758
    [Abstract] [Full Text] [Related]

  • 11. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
    Lutalo T, Musoke R, Kong X, Makumbi F, Serwadda D, Nalugoda F, Kigozi G, Sewankambo N, Sekasanvu J, Wawer M, Gray R.
    AIDS; 2013 Oct 28; 27 Suppl 1():S27-34. PubMed ID: 24088681
    [Abstract] [Full Text] [Related]

  • 12. Hormonal contraception and the risk of HIV acquisition.
    Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, Mugerwa R, Padian N, Rugpao S, Brown JM, Cornelisse P, Salata RA, Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV) Study Group.
    AIDS; 2007 Jan 02; 21(1):85-95. PubMed ID: 17148972
    [Abstract] [Full Text] [Related]

  • 13. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
    Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, Ndinya-Achola JO, Jaoko W, Overbaugh J.
    AIDS; 2007 Aug 20; 21(13):1771-7. PubMed ID: 17690576
    [Abstract] [Full Text] [Related]

  • 14. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
    Smith JA, Beacroft L, Abdullah F, Buthelezi B, Makua M, Morroni C, Ramjee G, Velasquez C, Hallett TB.
    J Int AIDS Soc; 2020 Oct 20; 23(10):e25620. PubMed ID: 33030312
    [Abstract] [Full Text] [Related]

  • 15. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
    Morrison C, Fichorova RN, Mauck C, Chen PL, Kwok C, Chipato T, Salata R, Doncel GF.
    J Acquir Immune Defic Syndr; 2014 Jun 01; 66(2):109-17. PubMed ID: 24413042
    [Abstract] [Full Text] [Related]

  • 16. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, Patel S, Ahmed K, Ramjee G, Friedland B, Lahteenmaki P.
    AIDS; 2012 Feb 20; 26(4):497-504. PubMed ID: 22156973
    [Abstract] [Full Text] [Related]

  • 17. Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.
    Hapgood JP.
    AIDS Res Hum Retroviruses; 2020 May 20; 36(5):357-366. PubMed ID: 31797677
    [Abstract] [Full Text] [Related]

  • 18. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul 20; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 19. Incidence and risk factors for herpes simplex virus type 2 seroconversion among pregnant women in Uganda: A prospective study.
    Nakubulwa S, Kaye DK, Bwanga F, Tumwesigye NM, Nakku-Joloba E, Mirembe FM.
    J Infect Dev Ctries; 2016 Oct 31; 10(10):1108-1115. PubMed ID: 27801374
    [Abstract] [Full Text] [Related]

  • 20. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.
    Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM, Partners in Prevention HSV/HIV Transmission Study Team.
    Lancet Infect Dis; 2012 Jan 31; 12(1):19-26. PubMed ID: 21975269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.